Pfizer Stock Price and Value Analysis

Should you buy Pfizer stock? (NYSE:PFE). Let's see how it does in our automated value investing analysis system.

PFE Free Cash Flow Trend

Free Cash Flow trendline for PFE
Free Cash Flow trendline for Pfizer

Based on historical returns, we believe that Pfizer can grow its free cash at a rate of about 2%. That's positive!

  • This company is a well-established bedrock.
  • This company has a large dividend yield!
  • This stock looks overpriced.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.

Inside the PFE Numbers

PFE Price
(Pfizer stock price per share)
PFE Fair Price
(based on intrinsic value)
PFE Safety Price (based on a variable margin of safety) $26.62
PE Ratio versus Sector 20% lower than other Healthcare stocks
PE Ratio versus Industry 6% lower than other Drug Manufacturers - Major stocks
Cash Yield 9.48%
Free Cash Flow Jitter 47%
Dividend Yield 4%

Is Pfizer Stock on Sale?

We believe that Pfizer may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Pfizer looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy PFE Stock?

Does Pfizer have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.